Blog
RSS FeedPosted by Michael Wonder on 10 May 2017
MTPConnect welcomes 2017 Budget: investment in MTP research translation and commercialisation
10 May 2017 - MTPConnect – the Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP) sector – has ...
Posted by Michael Wonder on 09 May 2017
Strategic Agreement between the Innovative pharmaceutical industry and government delivers certainty for industry, savings to taxpayers and benefits to patients
9 May 2017 - Medicines Australia has signed a strategic agreement with the Australian Government that will support ongoing access ...
Posted by Michael Wonder on 27 Apr 2017
New Government ‘must be more ambitious in securing a world-class NHS’, says UK pharmaceutical industry
27 April 2017 - The new Government must be more ambitious in securing a world-class NHS for patients and improve ...
Posted by Michael Wonder on 18 Apr 2017
Peak bodies unite against threat to commercialisation of Australian medical research
18 April 2017 - AusBiotech has joined fellow organisations - Research Australia, Medicines Australia, Medical Technologies Association of Australia and ...
Posted by Michael Wonder on 10 Apr 2017
QUT, MTPConnect and industry partnership will help to ensure Australia stays globally competitive
10 April 2017 - Medicines Australia warmly welcomes the commencement of The Bridge Program – an initiative of a consortium ...
Posted by Michael Wonder on 06 Apr 2017
AusBiotech says R&D Tax Incentive critical to 2030 Innovation Strategy
6 April 2017 - Preserving the R&D Tax Incentive will be top priority as AusBiotech coordinates comment for Innovation and ...
Posted by Michael Wonder on 08 Mar 2017
High U.S. drug prices cannot be explained by R&D spending alone
7 March 2017 - Pharmaceutical companies often cite research and development spending to justify high drug prices in the U.S. ...
Posted by Michael Wonder on 01 Mar 2017
WHO stresses urgent need for R&D for drug-resistant TB alongside newly-prioritized antibiotic-resistant pathogens
28 February 2017 - WHO reaffirms the critical need for research and development of new antibiotics to tackle the threat ...
Posted by Michael Wonder on 27 Feb 2017
WHO publishes list of bacteria for which new antibiotics are urgently needed
27 February 2017 - The World Health Organization today published its first ever list of antibiotic-resistant "priority pathogens"-a catalogue of ...
Posted by Michael Wonder on 07 Feb 2017
Privatised pharmaceutical innovation vs access to essential medicines: a global framework for equitable sharing of benefits
7 February 2017 - The effect of the current privatized model of pharmaceutical innovation on the development and affordability of lifesaving ...
Posted by Michael Wonder on 06 Feb 2017
Greg Hunt's innovation fund sent back to drawing board
5 February 2017 - Former industry minister Greg Hunt's $500 million national innovation fund has been sent back to the ...
Posted by Michael Wonder on 24 Jan 2017
Government seeks further comment on Productivity Commission's intellectual property report
24 January 2017 - The Federal Government has invited stakeholder views after releasing the final report on the Productivity Commission’s ...
Posted by Michael Wonder on 24 Jan 2017
Blame technology, not longer life spans, for health spending increases
23 January 2017 - American life spans are rising, and as they are, health care spending is, too. But longevity ...
Posted by Michael Wonder on 24 Jan 2017
MTPConnect and Medicines Australia sign MoU to boost Australia’s innovative medicines sector
24 January 2017 - MTPConnect – the Medical Technologies, Biotechnologies and Pharmaceuticals Industry Growth Centre – and Medicines Australia – ...
Posted by Michael Wonder on 08 Jan 2017
Don’t thank big government for medical breakthroughs
5 January 2017 - New cures come from private research, not cash dumped into the National Institutes of Health. ...